Analyze Diet
Equine veterinary journal1996; 28(5); 382-389; doi: 10.1111/j.2042-3306.1996.tb03109.x

Endotoxin induced expression of tumour necrosis factor, tissue factor and plasminogen activator inhibitor activity by peritoneal macrophages.

Abstract: Peritoneal fluid was collected aseptically from 30 healthy adult horses and 115 horses with acute gastrointestinal disease and supernatant was separated from cells by centrifugation followed by freezing until assayed for endotoxin and tumour necrosis factor activity. Peritoneal macrophages obtained from healthy horses were incubated in vitro for 3, 6, 12 or 24 h in the absence (media control) or presence of Escherichia coli 055:B5 endotoxin (final concentrations of 1, 10, 100 or 1000 ng/ml). Macrophages obtained from horses with acute gastrointestinal disease were incubated for 12 h in the absence (media control) or presence of 100 ng endotoxin/ml. At the conclusion of the incubation, macrophage supernatants were collected and frozen at -70 degrees C until analysed for tumour necrosis factor activity. Macrophage membranes were lysed and frozen at -70 degrees C until assayed for tissue factor and plasminogen activator inhibitor type 2 activity. Compared to cells incubated with media, incubation of macrophages, obtained from healthy horses, with endotoxin significantly increased tumour necrosis factor, tissue factor and plasminogen activator inhibitor type 2 activity. These increases were dependent on the endotoxin concentration and the duration of incubation. Compared to cells incubated with media alone, incubation of macrophages, obtained from horses with acute gastrointestinal disease with endotoxin, significantly increased tumour necrosis factor and tissue factor activity. Endotoxin induced tumour necrosis factor activity in vitro was significantly less for macrophages from horses with acute gastrointestinal disease, as compared to that produced by similarly treated cells obtained from healthy horses. For those horses with acute gastrointestinal disease, macrophages obtained from horses with either endotoxin or tumour necrosis factor activity in the peritoneal fluid supernatant had significantly less endotoxin induced tumour necrosis factor in vitro, as compared to similarly treated cells obtained from horses without endotoxin or tumour necrosis factor activity in the peritoneal fluid supernatant. The results of this study indicate that exposure of equine peritoneal macrophages to endotoxin results in a significant increase in tumour necrosis factor, tissue factor and plasminogen activator inhibitor type 2 activity. After in vitro exposure to endotoxin, there is significant down-regulation of inflammatory mediator production by peritoneal macrophages obtained from endotoxaemic horses. These results suggest that these macrophages may exhibit early endotoxin tolerance.
Publication Date: 1996-09-01 PubMed ID: 8894536DOI: 10.1111/j.2042-3306.1996.tb03109.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study explores how exposure to endotoxin affects the behavior of peritoneal macrophages in horses, revealing a significant increase in the activity of tumour necrosis factor, tissue factor and plasminogen activator inhibitor type 2. Interestingly, in horses suffering from acute gastrointestinal disease, these macrophages may express early endotoxin tolerance.

Research Method

  • The researchers collected peritoneal fluid from 30 healthy adult horses and 115 horses with acute gastrointestinal disease. This fluid was then separated into cells and supernatant via centrifugation and preserved by freezing.
  • Peritoneal macrophages from healthy horses were exposed to varying concentrations of Escherichia coli 055:B5 endotoxin over different time periods. Those from horses with gastrointestinal disease were exposed to a fixed amount of endotoxin over a fixed time period.
  • Upon completion of the incubation periods, the macrophage supernatants were collected and preserved at extremely low temperatures for subsequent analysis of tumour necrosis factor activity. Similarly, macrophage membranes were treated, frozen, and later assayed for tissue factor and plasminogen activator inhibitor type 2 activity.

Results

  • Exposure to endotoxin increased tumour necrosis factor, tissue factor, and plasminogen activator inhibitor type 2 activity in macrophages from healthy horses. The degree of increase was found to be dependent on the concentration of endotoxin and the duration of incubation.
  • In horses with acute gastrointestinal disease, endotoxin also induced an increase in tumour necrosis factor and tissue factor activity. However, the increase in tumour necrosis factor activity was significantly less than that observed in healthy horses.
  • Uniquely, if horses with gastrointestinal disease already had endotoxin or tumour necrosis factor activity in their peritoneal fluid supernatant, their macrophages showed even less endotoxin-induced tumour necrosis factor activity.

Conclusions

  • The increased activity of tumour necrosis factor, tissue factor, and plasminogen activator inhibitor type 2, induced by endotoxin exposure, demonstrates the significant role that these elements play in the immune response.
  • In the case of horses with acute gastrointestinal disease, a notable down-regulation of inflammatory mediator production was observed when macrophages were exposed to endotoxin. This suggests the possible occurrence of early endotoxin tolerance, potentially affecting the body’s ability to react to the disease.

Cite This Article

APA
Barton MH, Collatos C, Moore JN. (1996). Endotoxin induced expression of tumour necrosis factor, tissue factor and plasminogen activator inhibitor activity by peritoneal macrophages. Equine Vet J, 28(5), 382-389. https://doi.org/10.1111/j.2042-3306.1996.tb03109.x

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 28
Issue: 5
Pages: 382-389

Researcher Affiliations

Barton, M H
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens 30602, USA.
Collatos, C
    Moore, J N

      MeSH Terms

      • Acute Disease
      • Animals
      • Ascitic Fluid / pathology
      • Ascitic Fluid / veterinary
      • Cell Count / veterinary
      • Endotoxins / toxicity
      • Escherichia coli
      • Female
      • Gastrointestinal Diseases / immunology
      • Gastrointestinal Diseases / metabolism
      • Gastrointestinal Diseases / pathology
      • Gastrointestinal Diseases / veterinary
      • Horse Diseases / immunology
      • Horse Diseases / metabolism
      • Horse Diseases / pathology
      • Horses / immunology
      • Horses / metabolism
      • Macrophages, Peritoneal / drug effects
      • Macrophages, Peritoneal / immunology
      • Macrophages, Peritoneal / metabolism
      • Male
      • Plasminogen Activator Inhibitor 2 / biosynthesis
      • Thromboplastin / biosynthesis
      • Tumor Necrosis Factor-alpha / biosynthesis

      Citations

      This article has been cited 3 times.
      1. Andreassen SM, Berg LC, Nielsen SS, Kristensen AT, Jacobsen S. mRNA expression of genes involved in inflammation and haemostasis in equine fibroblast-like synoviocytes following exposure to lipopolysaccharide, fibrinogen and thrombin. BMC Vet Res 2015 Jun 27;11:141.
        doi: 10.1186/s12917-015-0448-zpubmed: 26116380google scholar: lookup
      2. Karagianni AE, Kapetanovic R, McGorum BC, Hume DA, Pirie SR. The equine alveolar macrophage: functional and phenotypic comparisons with peritoneal macrophages. Vet Immunol Immunopathol 2013 Oct 1;155(4):219-28.
        doi: 10.1016/j.vetimm.2013.07.003pubmed: 23978307google scholar: lookup
      3. Lacerenza MD, Arantes JA, Reginato GM, Passarelli D, Balieiro JCC, Amaral AR, Vendramini THA, Brunetto MA, Dória RGS. Effects of β-Glucan Supplementation on LPS-Induced Endotoxemia in Horses. Animals (Basel) 2024 Jan 31;14(3).
        doi: 10.3390/ani14030474pubmed: 38338117google scholar: lookup